| Title : Effect of treatment for 12 weeks with rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-positron emission tomography imaging - |
| Author(s) : Tawakol A , Singh P , Rudd JH , Soffer J , Cai G , Vucic E , Brannan SP , Tarka EA , Shaddinger BC , Sarov-Blat L , Matthews P , Subramanian S , Farkouh M , Fayad ZA |
| Ref : J Am Coll Cardiol , 63 :86 , 2014 |
| PubMedID: 23973698 |
Tawakol A, Singh P, Rudd JH, Soffer J, Cai G, Vucic E, Brannan SP, Tarka EA, Shaddinger BC, Sarov-Blat L, Matthews P, Subramanian S, Farkouh M, Fayad ZA (2014)
Effect of treatment for 12 weeks with rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-positron emission tomography imaging
J Am Coll Cardiol
63 :86
Tawakol A, Singh P, Rudd JH, Soffer J, Cai G, Vucic E, Brannan SP, Tarka EA, Shaddinger BC, Sarov-Blat L, Matthews P, Subramanian S, Farkouh M, Fayad ZA (2014)
J Am Coll Cardiol
63 :86